Analysis of the antigen-specificity and the T-cell receptor repertoire of NKG2C+ P CTL are ongoing and will accelerate the development of this CD8+ T cell-subset as a target for the prevention and therapy of infections with mycobacteria. Here, KLRC2 is linked to infection.